ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia

N Engl J Med. 2017 Jul 20;377(3):296-297. doi: 10.1056/NEJMc1705994.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Angiopoietin-Like Protein 3
  • Angiopoietin-like Proteins
  • Angiopoietins / antagonists & inhibitors*
  • Antibodies, Monoclonal / therapeutic use*
  • Cholesterol, LDL / blood*
  • Genotype
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / drug therapy*
  • Hyperlipoproteinemia Type II / genetics
  • Receptors, LDL / drug effects
  • Receptors, LDL / genetics
  • Receptors, LDL / metabolism

Substances

  • ANGPTL3 protein, human
  • Angiopoietin-Like Protein 3
  • Angiopoietin-like Proteins
  • Angiopoietins
  • Antibodies, Monoclonal
  • Cholesterol, LDL
  • Receptors, LDL
  • evinacumab